Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.

Caffeic Acid Inhibits Colitis In A Mouse Model
Researchers at Iowa State University have found that increased expression of a form of cytochrome P-450 (CYP4B1) is a key marker of inhibition of colitis in mice by caffeic acid, an anti-inflammatory antioxidant compound widely distributed in foods. The results, which appear in the June 2009 issue of Experimental Biology and Medicine, implicate CYP4B1, a form of cytochrome P450 previously found to be associated with resolution of allergic inflammation in another model. The normalization of CYP4B1 by caffeic acid treatment was associated with significant lessening of colitic damage, assessed by examining colon histopathology. In comparison with rutin, an anti-inflammatory flavonoid and hypoxoside extract, a botanical known as African potato previously shown to protect against colitis, all three compounds had anti-inflammatory effects, suppressing myeloperoxidase, IL-17 and iNOS and increasing IL-4, known factors associated with inflammation responses. But only caffeic acid protected against the dextran sulfate sodium induced colitis. Its novel mechanism related to CYP4B1 is being studied further. The research team, Zhong Ye, a graduate student in Toxicology, along with Microbiology graduate students Zhiping Liu and Abigail Henderson, Visiting Scientist Kwangwon Lee, Korea University, Dr. Michael Wannemuehler, Veterinary Microbiology, Dr. Jesse Hostetter, a veterinary pathologist, and Dr. Suzanne Hendrich, Toxicologist and Nutritionist, performed studies in 8 week old mice fed the various dietary components and then exposed to dextran sulfate sodium in a mildly irritating dose to induce colitis. Dr. Hendrich noted that "this study of caffeic acid will help us to advance studies of botanicals and plant foods with respect to their ability and mechanisms of inhibiting colitis, and perhaps colon cancer, because colitis increases risk for this disease".
News of the day
MU Public Health Program Receives Grant To Combat Human Trafficking
After drug dealing, trafficking of humans is tied with arms dealing as the second largest criminal industry in the world, and it is the fastest growing, according to the U.S. Department of Health and Human Services (HHS). Recently, HHS awarded more than $2 million in grants to state and local organizations, including the University of Missouri, to identify and help victims of human trafficking.
Medical Devices

Canada Continues To Work With National And International Partners To Manage The Spread Of The H1N1 Flu Virus

Health Minister Leona Aglukkaq updated Canadians on the H1NI flu virus response and reemphasized the Government of Canada"s ongoing collaboration with its national and international partners to manage the spread of this virus. The Minister and Canada"s Chief Public Health Officer, Dr. David Butler-Jones will be participating in an international meeting on the global response to H1N1 flu virus in Cancun, Mexico from July 1-3. "The Government of Canada continues to work closely with our Canadian and international partners to monitor and manage the spread of H1N1," said Minister Aglukkaq. "The Cancun meeting will provide us with an opportunity to learn more about the virus, evaluate our response thus far, and strengthen our plans for the future." The following highlights some of the latest information on the virus as well as a number of activities the Government of Canada is taking in specific areas to address the illness. In Canada, while new cases of H1N1 flu virus continue to emerge, the majority of cases do not require hospitalization. Preliminary data shows that the majority of those infected with H1N1 are under the age of 20, and that relatively few people over the age of 65 have contracted the virus. The average age of persons in Canada with H1N1 flu virus infection is 22 (median 17), with an age range of those infected between 1 and 97 years. During seasonal influenza, people over 65 usually account for about a quarter of overall infections. The Public Health Agency of Canada is still collecting information on the hospitalized cases of H1N1, but early data for a third of the reported cases shows that about 30 per cent involve either pregnant women or people with underlying conditions like lung disease, heart disease, immunodeficiency, and diabetes. The Government of Canada continues to work with all partners to address H1N1 throughout Canada. While the majority of cases are mild, there are some pockets of severe illness in Canada, including in some remote First Nations communities. The Government of Canada continues to implement its pandemic plan across the country with the partnership of the provinces, territories and First Nation communities. Some actions that have been taken in remote First Nations communities include the dispatching of additional doctors and nurses and ensuring that nursing stations in remote First Nations communities have necessary supplies for health care workers caring for suspected cases of H1N1. Antivirals have been shipped to affected communities and Health Canada is working to ensure that additional requirements are met as needed. Epidemiologists are also studying the virus and how it is spreading in First Nation communities. Finally, those First Nations patients living in remote communities who show signs of serious illness continue to be transported to hospitals, as they have from the beginning of the outbreak. "As with any plan, we have to adapt to the situation at hand, and the unique characteristics of individual communities," said Dr. David Butler-Jones, Canada"s Chief Public Health Officer. "We are working with provincial health officials and First Nation leadership to implement our pandemic plan." For more information, visit http://www.fightflu.ca. Government of Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009